These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 22981028)

  • 1. [Information on legal issues in health technologies: methodological proposal to identify them in a systematic and comprehensible manner].
    Droste S; Rixen S
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(7):509-22. PubMed ID: 22981028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Systematic literature search to make HTA (health technology assessment) reports].
    Droste S
    Z Arztl Fortbild Qualitatssich; 2001 Aug; 95(8):549-53. PubMed ID: 11575138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Information on ethical issues in health technology assessment: how and where to find them.
    Droste S; Dintsios CM; Gerber A
    Int J Technol Assess Health Care; 2010 Oct; 26(4):441-9. PubMed ID: 20923585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organizational and patient-related assessments in HTAs: state of the art.
    Lee A; Skött LS; Hansen HP
    Int J Technol Assess Health Care; 2009 Oct; 25(4):530-6. PubMed ID: 19845983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [SR/PS-method for using data of primary studies from systematic reviews in the evaluation of health technologies].
    Gorenoi V; Hagen A
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(5-6):325-32. PubMed ID: 25066352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New technologies and surgical innovation: five years of a local health technology assessment program in a surgical department.
    Poulin P; Austen L; Kortbeek JB; Lafrenière R
    Surg Innov; 2012 Jun; 19(2):187-99. PubMed ID: 21949011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditionally funded field evaluations and practical trial design within a health technology assessment framework.
    Bowen JM; Patterson LL; O'Reilly D; Hopkins RB; Blackhouse G; Burke N; Xie F; Tarride JE; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):324-31. PubMed ID: 19394573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Assessment of benefit and efficiency of innovative medical devices].
    Perleth M; Lühmann D
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Aug; 53(8):825-30. PubMed ID: 20700782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management, part I: introduction and general considerations.
    Manchikanti L
    Pain Physician; 2008; 11(2):161-86. PubMed ID: 18354710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HTA in the decision-making processes of health care institutions. Current state and relevant questions of regulatory health law].
    Francke R; Hart D
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):241-50. PubMed ID: 16482461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How well do search filters perform in identifying economic evaluations in MEDLINE and EMBASE.
    Glanville J; Kaunelis D; Mensinkai S
    Int J Technol Assess Health Care; 2009 Oct; 25(4):522-9. PubMed ID: 19845982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patent law--balancing profit maximization and public access to technology.
    Beckerman-Rodau A
    Columbia Sci Technol Law Rev; 2003; 4():E1. PubMed ID: 15977333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence Review Group approaches to the critical appraisal of manufacturer submissions for the NICE STA process: a mapping study and thematic analysis.
    Kaltenthaler E; Boland A; Carroll C; Dickson R; Fitzgerald P; Papaioannou D
    Health Technol Assess; 2011 May; 15(22):1-82, iii-iv. PubMed ID: 21561569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scanning the horizon of obsolete technologies: possible sources for their identification.
    Ibargoyen-Roteta N; Gutierrez-Ibarluzea I; Asua J; Benguria-Arrate G; Galnares-Cordero L
    Int J Technol Assess Health Care; 2009 Jul; 25(3):249-54. PubMed ID: 19619342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health technology assessment.
    Hailey D
    Singapore Med J; 2006 Mar; 47(3):187-92; quiz 193. PubMed ID: 16518551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.